The Netherlands Cancer Institute clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

1. Notable

   TARZAN · Neoadjuvant Treatment in Rectal Cancer With Radiotherapy…TARZAN · Neoadjuvant Treatment in Rectal Cancer With Radiotherapy Followed by Atezolizumab and Bevacizumab (TARZAN)

   Primary and study completion pushed from Aug 31, 2025 to Dec 31, 2028

   The Netherlands Cancer Institute·Phase 2· NCT04017455· Registry history of NCT04017455 on ClinicalTrials.gov (opens the registry)

   Sep 30, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.